卫信康：子公司琥珀酰明胶注射液获药物临床试验批准

Core Viewpoint - The company Weixin Kang (603676) announced that its wholly-owned subsidiary, Inner Mongolia Baiyi Pharmaceutical Co., Ltd., has received the clinical trial approval notice for Succinyl Gelatin Injection from the National Medical Products Administration [1] Group 1 - The Succinyl Gelatin Injection is a colloidal volume substitute used for the treatment of relative or absolute hypovolemia and shock [1]